Study finds psychedelics may improve decision-making in mice
Most psychiatric medications available today were first developed in the 1950s, leaving limited options for the one-in-five Americans with mental health conditions. New research from Boston University offers a different approach: psychedelics, a class of drugs many hope could provide relief for depression and anxiety.
According to Medical Xpress, researchers at Boston University trained mice to use light signals to find rewards. Untreated mice performed the task but made mistakes, often returning to the same location regardless of the signals. After receiving psilocybin or ketamine, the mice performed better and made fewer mistakes by relying less on habits and more on the relevant signals.
The study, published in Science Advances, suggests psychedelics reduce reliance on habits and repetitive choices, which may explain part of their therapeutic effect. According to the research, psychedelic drugs have shown potential as treatments, with studies reporting meaningful benefits in patients with depression after a single dose of psilocybin, with benefits lasting long after the drug's immediate effects wear off.
However, how psychedelics change the brain to produce their therapeutic and mind-altering effects remains poorly understood, according to the researchers.
What it means in Raleigh
Behavioral health: Alliance Health (LME/MCO for Wake, Durham, Johnston, Orange, Cumberland, Mecklenburg)
Medicaid plans: NC Medicaid Standard Plans: AmeriHealth Caritas NC, Carolina Complete Health, Healthy Blue, UnitedHealthcare Community Plan, WellCare of NC. Tailored Plans: Alliance Health, Trillium Health Resources, Vaya Partners (Vaya Health + Partners Health Management, merged 2026).
Major insurers: Blue Cross NC, Aetna, Cigna, UnitedHealthcare, Humana
Plan lists change; confirm with your plan or the state agency.
